Author:
Thummuri Dinesh,Naidu V. G. M.,Chaudhari Pradip
Funder
DBT
Financial support from Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Drug Discovery,Molecular Medicine
Reference40 articles.
1. Zheng M, Phan T, Xu J (2004) Interaction between osteoblast and osteoclast: impact in bone disease. Histol Histopathol 19:1325–1344
2. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337–342
3. Takayanagi H (2005) Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med (Berl) 83:170–179
4. Asagiri M, Takayanagi H (2007) The molecular understanding of osteoclast differentiation. Bone 40:251–264
5. Lee J-H, Jin H, Shim H-E, Kim H-N, Ha H, Lee ZH (2010) Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-κB signal. Mol Pharmacol 77:17–25
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献